252 results on '"Boveri E"'
Search Results
2. Extramedullary hematopoiesis: a new feature of inherited thrombocytopenias?
3. P982: MYELOID-DERIVED SUPPRESSOR CELLS: CHARACTERIZATION IN PERIPHERAL BLOOD AND SPLEEN TISSUE OF PATIENTS WITH MYELOFIBROSIS
4. Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes
5. Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms
6. Subcutaneous ‘lipoma-like’ B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT
7. Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes
8. Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients
9. A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications
10. Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes
11. Venetoclax and azacytidine combination is an effective bridge to transplant strategy in relapsed/refractory acute myeloid leukemia patients
12. Indolent systemic mastocytosis treated with narrow-band UVB phototherapy: study of five cases
13. Cathepsin D and E co-expression in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) and Langerhans' cell histiocytosis: further evidences of a phenotypic overlap between these histiocytic disorders
14. Sinus histiocytosis with massive lymphoadenopathy (Rosai-Dorfman disease). Clinico-pathological analysis of a paediatric case
15. Nodular sclerosing Hodgkin's disease and large cell lymphoma. Immunophenotypic characterization of a composite case
16. Lymph node reticulum cell neoplasm with progression into cytokeratin-positive interstitial reticulum cell (CIRC) sarcoma: a case study
17. Anaplastic large cell lymphoma, CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen: Immunohistochemical and morphological relationships to Hodgkin's disease
18. Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma
19. PF669 RUXOLITINIB TREATMENT AND RISK OF B-CELL LYMPHOMAS IN MYELOPROLIFERATIVE NEOPLASMS
20. Neuroendocrine cell proliferation associated with primary pulmonary MALT lymphoma
21. A VLSI processor for concurrent list intersection
22. THE ITALIAN MASTOCYTOSIS REGISTRY: THE FIRST FIVE YEARS
23. Nationwide interobserver variation in the diagnosis of follicular lymphoma. A study of the pathologists of GISL (Gruppo Italiano Studi Linfomi)
24. The 'gray zone' of the Ph-negative myeloproliferative neoplasm; proposal of a decision tree useful in the differential diagnosis
25. Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis
26. Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis
27. False versus true ET. Morphologic, immunophenotypic and molecular features
28. Splenic marginal zone lymphoma: A prognostic model for clinical use
29. Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms
30. A prognostic model to predict survival in 867 WHO-defined essential thrombocythemia at diagnosis: a study by the IWG-MRT
31. Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry
32. First case of an AIDS patient with systemic mast cell disease associated with FIP1-positive eosinophilia treated with imatinib mesylate therapy
33. Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination. Oncologist
34. Nongastric marginal zone B-cell lymphoma of MALT: prognostic value of disease dissemination
35. Bone Marrow evaluation according to the PVSG and WHO criteria in 90 essential thrombocythemia (ET) patients treated with PEG interferon alpha-2b. Preliminary results
36. Accidents de couchage et de portage
37. Diffuse alveolar hemorrhage as a manifestation of Behçet disease
38. Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia
39. Pilomatrixoma: A case report
40. European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360-5 - Comment
41. Indolent systemic mastocytosis treated with narrow-band UVB phototherapy: study of five cases
42. 71 Pathogenetic and prognostic role of vascular endothelial growth factor in myelodysplastic syndromes
43. Primary gastric CD30 (Ki-1)-positive large cell non-Hodgkin's lymphomas. A clinicopathologic analysis of six cases
44. Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients
45. Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSS
46. Cathepsin E in antigen-processing Langerhans and interdigitating reticulum cells. Its possible role in antigen processing
47. C-erbB-2 protein in serum and breast cancer tissue. Correlation in high-grade ductal cancer
48. Myelofibrotic transformation in essential thrombocythemia. Author reply
49. CD146+ bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis
50. Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.